Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
MicroRNA Regulation of Calcium Handling in Atrial Fibrillation
FY 2013-14
Summary
Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting nearly 350,000 individuals in Canada alone. It is a disease where the electrical rhythm controlling the heartbeat is irregular and faster than it should be. It is commonly associated with increased cardiovascular mortality, with stroke being the most common and deadly complication. Available drug options are limited; often they are ineffective or increase the risk of developing life-threatening ventricular arrhythmias. Investigating the molecular mechanisms of how atrial fibrillation develops is necessary to identify targets for treatment and ultimately improve its management.
Cellular processes throughout the body are governed by small molecules called microRNAs. There are currently over 1000 discovered and many more will likely follow. When abnormal levels of a microRNA come about, diseases can develop, including atrial fibrillation. However, the specific cellular process(es) each microRNA targets is often unknown. They can be predicted through computer analysis of the microRNA structure, but biological experimentation is always necessary. There are a number of microRNAs in the heart predicted to govern the process of calcium handling. This is of particular interest because calcium is crucial for normal heart function, being involved in muscle contraction and rhythm pacing, while also determining whether cells survive or die. Moreover, when calcium handling is disrupted, many heart diseases often result, such as atrial fibrillation.
Of these numerous microRNAs, three (miR-29b, -133 and -214) are implicated in congestive heart failure, a disease that often occurs alongside atrial fibrillation and has common mechanisms and treatment strategies. My project will examine whether enhancing or reducing each of these microRNAs induces atrial fibrillation and which particular component(s) of calcium handling they target. The results of my project will give significant insight into the role microRNAs play in atrial fibrillation development, while also potentially revealing new therapeutic targets to further the management of atrial fibrillation.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311882
Name
Duong Eric
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
MicroRNA Regulation of Calcium Handling in Atrial Fibrillation
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atrial Cardiomyocyte; Atrial Fibrillation; Calcium Signaling; Heart Disease; Hl-1 Cell Line; Microrna
Abstract
Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting nearly 350,000 individuals in Canada alone. It is a disease where the electrical rhythm controlling the heartbeat is irregular and faster than it should be. It is commonly associated with increased cardiovascular mortality, with stroke being the most common and deadly complication. Available drug options are limited; often they are ineffective or increase the risk of developing life-threatening ventricular arrhythmias. Investigating the molecular mechanisms of how atrial fibrillation develops is necessary to identify targets for treatment and ultimately improve its management.
Cellular processes throughout the body are governed by small molecules called microRNAs. There are currently over 1000 discovered and many more will likely follow. When abnormal levels of a microRNA come about, diseases can develop, including atrial fibrillation. However, the specific cellular process(es) each microRNA targets is often unknown. They can be predicted through computer analysis of the microRNA structure, but biological experimentation is always necessary. There are a number of microRNAs in the heart predicted to govern the process of calcium handling. This is of particular interest because calcium is crucial for normal heart function, being involved in muscle contraction and rhythm pacing, while also determining whether cells survive or die. Moreover, when calcium handling is disrupted, many heart diseases often result, such as atrial fibrillation.
Of these numerous microRNAs, three (miR-29b, -133 and -214) are implicated in congestive heart failure, a disease that often occurs alongside atrial fibrillation and has common mechanisms and treatment strategies. My project will examine whether enhancing or reducing each of these microRNAs induces atrial fibrillation and which particular component(s) of calcium handling they target. The results of my project will give significant insight into the role microRNAs play in atrial fibrillation development, while also potentially revealing new therapeutic targets to further the management of atrial fibrillation.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Duong, Eric
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~